Laparoscopic pancreatectomy for benign or low-grade malignant pancreatic tumors: outcomes in a single high-volume institution

Table 3 The demographic characteristics of three groups

Variables	LPPPD n = 83	LCP n = 20	LSPDP n = 41	P value
Variables	LPPPD n = 83	LCP n = 20	LSPDP n = 41	P₁	P₂
Age (years)	54.8 ± 13.4	48.8 ± 15.7	45.3 ± 14.4	0.084	0.466
Gender (male/female)	36/47	7/13	10/31	0.495	0.386
BMI (kg/m²)	21.5 ± 3.2	24.0 ± 3.7	22.0 ± 2.7	0.004	0.024
ASA score
II (n, %)	80 (96.4%)	17 (85.0%)	37 (90.2%)	0.086	0.674
III (n, %)	3 (3.6%)	3 (15.0%)	4 (9.8%)	0.086	0.674
Comorbidities* (n, %)	16 (19.3%)	7 (35.0%)	13 (31.7%)	0.224	0.797
History of abdominal surgery^†	13 (15.7%)	4 (20.0%)	10 (24.4%)	0.894	0.953
Hemoglobin (g/L)	124.2 ± 19.4	131.8 ± 7.6	127.5 ± 11.1	0.048	0.192
Albumin (g/L)	41.9 ± 3.7	42.5 ± 3.4	41.3 ± 4.1	0.484	0.229
Creatinine (μmol/L)	87.0 (72.0–98.0)	83.0 (57.5–98.8)	87.0 (67.0–98.5)	0.496	0.585

Bold value indicates statistical significance (P < 0.05; P₁: LPPPD group vs. LCP group; P₂: LSPDP group vs. LCP group)
LPPPD laparoscopic pylorus-preserving pancreaticoduodenectomy, LSPDP laparoscopic spleen-preserving distal pancreatectomy, LCP laparoscopic central pancreatectomy, BMI body mass index, ASA score American Society of Anesthesiologists classification score
*Comorbidities including chronic obstructive pulmonary disease, hypertension, diabetes and cardiovascular disease
^†History of abdominal surgery including cholecystectomy, appendectomy, biliary tract and gastric surgery

ISSN: 1471-2482